Research Grant RFPs
Learn about Research RFPs!
MRF Breakthrough Consortium Young Investigator Team Award to Advance the Field of Translational Immuno-Oncology (MRFBC)
The MRFBC Team Award provides funding of up to $150,000 per year for two years to an investigative team whose research focuses on either improving clinical outcomes for patients with melanoma being treated with immuno‐oncology agents or advancing the scientific understanding of immuno‐oncology and the role of the immune system in melanoma. Teams must involve collaborations from at least two different institutions, one of which must be a MRFBC member institution. Further, the proposed PI and all co-PIs must be junior scientists, all of whom have at least one mentor. Applications for 2024 grants will be accepted until March 1st, 2024 at 5pm ET. Additional information including eligibility requirements and applications instructions can be found in the 2024 Team/ EIA/ CDA Request for Proposals (RFP).
Established Investigator Awards (EIA)
The EIAs provide funding of up to $125,000 per year for two years to established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research. Applications for 2024 grants will be accepted until March 1st, 2024 at 5pm ET. Additional information including eligibility requirements and applications instructions can be found in the 2024 Team/ EIA/ CDA Request for Proposals (RFP).
Career Development Awards (CDA)
The CDAs provide funding of up to $50,000 per year for two years to junior investigators. Researchers who are beginning a research career focused on melanoma are eligible. This year, in addition to general CDAs, the MRF will offer the MRF Prevention Award in Honor of Teddi Mellencamp/ PREV CDA. Applications for 2024 grants will be accepted until March 1st, 2024 at 5pm ET. Additional information including eligibility requirements and applications instructions can be found in the 2024 Team/ EIA/ CDA Request for Proposals (RFP).
Advocate Grant Reviewer
Beginning in 2019, melanoma patient advocates were invited to participate in the grant review process to share their perspective on which areas of research should receive grant funding. The MRF is currently seeking melanoma patient advocates to join this year’s research grant review panel. Formal scientific training is not required, but those with such a background are welcome to apply. Applications for 2024 grants will be accepted until April 25th, 2024. Additional information including eligibility requirements, estimated time commitment and applications instructions can be found in the 2024 Advocate Grant Reviewer Application.
For any additional information or any questions, please email [email protected].
MRF Breakthrough Consortium (MRFBC) Pilot Translational Award Funded by the Brodman Charitable Fund & Friends
Applications are currently under review. This one-year pilot proposal for $50,000 focuses on clinical/ translational research. As this is a pilot award, preliminary data is not required. The goal of the pilot proposal is to create findings that could then lend themselves to larger, multicenter grant proposals.
Resident/Fellow Research Grants
Applications are currently under review. Due to the success of the Medical Student Research Grant program, in 2024 the MRF will introduce resident/fellow research grants as well. The purpose of these 1-year, $10,000 awards is to promote research opportunities to resident/fellows early in their careers by funding clinical or laboratory-based research projects focused on better understanding the prevention, early detection, behaviors that impact melanoma risk, biology and treatment of melanoma, including cutaneous, ocular, mucosal, pediatric, etc. In 2024, in addition to awards focused on any aspect of melanoma research, the MRF is pleased to also offer at least one award focused specifically on ocular melanoma research.
To receive announcements of future research funding opportunities, please fill out the form below:
The MRF has been funding peer-reviewed research since 1998. The foundation provides emerging and established scientific investigators with highly sought-after grants that allow them to explore new, high-impact avenues in melanoma research. The types of grants offered are noted below:
- Team Science Awards: The largest grant offered by the MRF, a Team Science Award, encourages collaboration across academic disciplines in an institution or among multiple institutions. Team Science Awards are required to address an unmet need or Special Topic area, as defined by the MRF’s Scientific Advisory Committee.
- Established Investigator Awards (EIA): Applicants must have at least a position of Associate Professor and a demonstrated research track record. This award encourages proven researchers to continue research on emerging challenges in melanoma. Ideally, this award will generate data that can justify a much larger competitive grant.
- Career Development Awards (CDA): This award enables young researchers to generate the groundwork that can leverage additional grant funding from other funding bodies. As such, recipients must be either postdoctoral fellows with less than five years of postdoctoral experience or a research associate, instructor, assistant professor, or the equivalent.
- Pilot Awards: The goal of this award is to create findings that could then lend themselves to larger, multicenter grant proposals. Both tenured and non-tenured track faculty are encouraged to apply.
- Resident/Fellow Awards: This grant is designed to fund clinical or laboratory melanoma research projects for resident/ fellows under the mentorship of a melanoma investigator.
- Medical Student Awards: The MRF is committed to introducing students early in their careers to the clinical or research opportunities under the mentorship of an investigator engaged in melanoma research.
Occasionally, we also have special opportunities available that do not adhere to our usual categories. Specific details and application instructions for each MRF research opportunity will be available in the relevant RFP.